VISEN PHARMA-B (02561): YAO Zhengbin (Bing) resigns as independent non-executive director.

22:16 27/08/2026

Weisheng Pharmaceutical-B (02561) announced that Dr. YAO Zhengbin (Bing) has resigned as an independent non-executive director due to other business commitments, and he will also no longer serve as a member of the companys nomination committee and audit committee, effective from August 27, 2026.

VISEN PHARMA-B (02561) announced that Dr. YAO Zhengbin (Bing) has resigned as an independent non-executive director due to other business commitments, and will no longer serve as a member of the company's nomination committee and audit committee, effective from August 27, 2026. In addition, independent non-executive director Mr. Zhang Qian has been appointed as a member of the nomination committee, while non-executive director Mr. Michael J. CHANG has been appointed as a member of the audit committee.

ZHONG JI LS (00767) released its interim results, reporting a loss attributable to shareholders of HKD 6.51 million, a year-on-year decrease of 48.21%.

JINYAN KAOLIN (02693) appoints Zhu Zejian as General Manager.

JINYAN KAOLIN (02693) released its interim results, with a profit attributable to shareholders of 7.966 million yuan, a year-on-year decrease of 64.89%.

ZHONG JI LS (00767) released its interim results, reporting a loss attributable to shareholders of HKD 6.51 million, a year-on-year decrease of 48.21%.

JINYAN KAOLIN (02693) appoints Zhu Zejian as General Manager.

JINYAN KAOLIN (02693) released its interim results, with a profit attributable to shareholders of 7.966 million yuan, a year-on-year decrease of 64.89%.